TherapeuticsMD, Inc. (TXMD) stock
TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 12/3029% below fair value
$1.91+0.10 (+5.52%)
Close on Nov 17, 2026Market cap $22.11MP/E –Yield –
TherapeuticsMD operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
TherapeuticsMD's operating cash flow for the twelve months ending Jun 30, 2026 was $3.10M, up 201.9% year over year. For fiscal 2025 it was $2.45M, up 109.7% from the year before. The highest annual figure on record is $9.36M in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.45M | +109.7% |
| FY2024 | Dec 31, 2024 | $1.17M | – |
| FY2023 | Dec 31, 2023 | -$23.08M | -346.6% |
| FY2022 | Dec 31, 2022 | $9.36M | – |
| FY2021 | Dec 31, 2021 | -$55.13M | – |
| FY2020 | Dec 31, 2020 | -$159.47M | – |
| FY2019 | Dec 31, 2019 | -$165.72M | – |
| FY2018 | Dec 31, 2018 | -$106.81M | – |
| FY2017 | Dec 31, 2017 | -$76.16M | – |
| FY2016 | Dec 31, 2016 | -$69.14M | – |
| FY2015 | Dec 31, 2015 | -$79.04M | – |
| FY2014 | Dec 31, 2014 | -$45.52M | – |
| FY2013 | Dec 31, 2013 | -$20.77M | – |
| FY2012 | Dec 31, 2012 | -$12.74M | – |
| FY2011 | Dec 31, 2011 | -$4.97M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $779.00K | +104.5% |
| Q1 FY2026 | Mar 31, 2026 | $944.00K | +35.1% |
| Q4 FY2025 | Dec 31, 2025 | $375.00K | +2105.9% |
| Q3 FY2025 | Sep 30, 2025 | $999.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $381.00K | -73.8% |
| Q1 FY2025 | Mar 31, 2025 | $699.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $17.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$71.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $1.45M | – |
| Q1 FY2024 | Mar 31, 2024 | -$229.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.96M | -116.4% |
| Q3 FY2023 | Sep 30, 2023 | -$6.03M | -134.0% |
| Q2 FY2023 | Jun 30, 2023 | -$3.39M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.70M | – |
| Q4 FY2022 | Dec 31, 2022 | $30.24M | -37.0% |
| Q3 FY2022 | Sep 30, 2022 | $17.72M | – |
| Q2 FY2022 | Jun 30, 2022 | -$20.72M | – |
| Q1 FY2022 | Mar 31, 2022 | -$17.87M | – |
| Q4 FY2021 | Dec 31, 2021 | $48.00M | – |
| Q3 FY2021 | Sep 30, 2021 | -$38.22M | – |
| Q2 FY2021 | Jun 30, 2021 | -$26.53M | – |
| Q1 FY2021 | Mar 31, 2021 | -$38.38M | – |
| Q4 FY2020 | Dec 31, 2020 | -$30.36M | – |
| Q3 FY2020 | Sep 30, 2020 | -$34.05M | – |
| Q2 FY2020 | Jun 30, 2020 | -$55.95M | – |
| Q1 FY2020 | Mar 31, 2020 | -$39.11M | – |
| Q4 FY2019 | Dec 31, 2019 | -$50.82M | – |
| Q3 FY2019 | Sep 30, 2019 | -$26.22M | – |
| Q2 FY2019 | Jun 30, 2019 | -$50.51M | – |
| Q1 FY2019 | Mar 31, 2019 | -$38.16M | – |
| Q4 FY2018 | Dec 31, 2018 | -$28.14M | – |
| Q3 FY2018 | Sep 30, 2018 | -$34.07M | – |
| Q2 FY2018 | Jun 30, 2018 | -$24.95M | – |
| Q1 FY2018 | Mar 31, 2018 | -$19.65M | – |
| Q4 FY2017 | Dec 31, 2017 | -$20.81M | – |
| Q3 FY2017 | Sep 30, 2017 | -$16.68M | – |
| Q2 FY2017 | Jun 30, 2017 | -$18.14M | – |
| Q1 FY2017 | Mar 31, 2017 | -$20.53M | – |
| Q4 FY2016 | Dec 31, 2016 | -$15.62M | – |
| Q3 FY2016 | Sep 30, 2016 | -$18.80M | – |
See a number that looks wrong?